.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Moodys
Chinese Patent Office
Daiichi Sankyo
Express Scripts
Boehringer Ingelheim
Deloitte
Harvard Business School
Medtronic
Citi

Generated: June 27, 2017

DrugPatentWatch Database Preview

ANEXSIA 7.5/325 Drug Profile

« Back to Dashboard

Which patents cover Anexsia 7.5/325, and what generic Anexsia 7.5/325 alternatives are available?

Anexsia 7.5/325 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in ANEXSIA 7.5/325 is acetaminophen; hydrocodone bitartrate. There are sixty-five drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; hydrocodone bitartrate profile page.

Summary for Tradename: ANEXSIA 7.5/325

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list6
Bulk Api Vendors: see list98
Clinical Trials: see list159
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANEXSIA 7.5/325 at DailyMed

Pharmacology for Tradename: ANEXSIA 7.5/325

Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt
ANEXSIA 7.5/325
acetaminophen; hydrocodone bitartrate
TABLET;ORAL040405-001Sep 8, 2000AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
Express Scripts
Federal Trade Commission
Colorcon
Cantor Fitzgerald
Merck
Moodys
Argus Health
Farmers Insurance
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot